海印股份(000861.SZ)與許啟太、今珠公司解除“今珠多糖注射液”相關合作合同
格隆匯5月25日丨海印股份(000861.SZ)公佈,2020年5月25日,公司與許啟太、海南今珠農業發展有限公司(“今珠公司”)簽署《<合作合同>解除協議》。
公司於2019年6月11日召開第九屆董事會第十五次臨時臨時會議,審議通過了《關於簽署<合作合同>的議案》,同意公司與許啟太、今珠公司簽署《合作合同》。
現因許啟太、今珠公司無法在合同約定時間內取得“今珠多糖注射液”的生產和銷售許可,經三方協商一致,同意解除《合作合同》。
因合作方無法在《合作合同》約定時間內取得“今珠多糖注射液”的生產和銷售許可,經董事會慎重研究,為減少公司投資風險,維護公司及全體股東利益,決定解除《合作合同》。
解除協議的簽署不會對公司的日常經營產生影響,也不存在損害公司股東尤其中小股東合法利益的情形。合作解除後對公司本期和未來財務狀況和經營成果不會構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.